Other disciplines of study, such as Environmental chemistry and Inorganic chemistry, are mixed together with his Organic chemistry studies. Ryan J. Sullivan integrates Inorganic chemistry and Organic chemistry in his studies. The study of Mineral dust, Cloud condensation nuclei and Sea salt are components of his Aerosol research. His Mineral dust study frequently links to related topics such as Aerosol. There are a combination of areas like Gene and Cancer research integrated together with his Genetics study. Gene and Genetics are two areas of study in which Ryan J. Sullivan engages in interdisciplinary research. He integrates Meteorology with Climatology in his study. Ryan J. Sullivan integrates Climatology with Meteorology in his study. In his works, Ryan J. Sullivan undertakes multidisciplinary study on Atmospheric sciences and Oceanography.
Among his Cancer research studies, you can observe a synthesis of other disciplines of science such as Melanoma and Cancer. He performs integrative study on Cancer and Cancer research in his works. Borrowing concepts from Oncology, he weaves in ideas under Internal medicine. He integrates Oncology with Internal medicine in his study. While working on this project, he studies both Organic chemistry and Environmental chemistry. Ryan J. Sullivan connects Environmental chemistry with Organic chemistry in his research. He connects Meteorology with Atmospheric sciences in his study. He incorporates Atmospheric sciences and Meteorology in his research. His study ties his expertise on Particle (ecology) together with the subject of Oceanography.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh;Benjamin Izar;Benjamin Izar;Sanjay M. Prakadan;Marc H. Wadsworth.
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor
Y Shing;J Folkman;R Sullivan;C Butterfield.
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Daniel Y. Wang;Joe Elie Salem;Joe Elie Salem;Justine V. Cohen;Sunandana Chandra.
JAMA Oncology (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.
Moshe Sade-Feldman;Moshe Sade-Feldman;Keren Yizhak;Stacey L. Bjorgaard;Stacey L. Bjorgaard;John P. Ray.
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
Dennie Tompers Frederick;Adriano Piris;Alexandria P. Cogdill;Zachary A. Cooper.
Clinical Cancer Research (2013)
EGFR Mutations and ALK Rearrangements Are Associated With Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor;Alice T. Shaw;Lecia V. Sequist;Xiujun Fu.
Clinical Cancer Research (2016)
MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Syed S. Mahmood;Michael G. Fradley;Justine V. Cohen;Anju Nohria.
Journal of the American College of Cardiology (2018)
Transforming fusions of FGFR and TACC genes in human glioblastoma
Devendra Singh;Joseph Minhow Chan;Pietro Zoppoli;Francesco Niola;Francesco Niola.
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon;Parin Shah;Michael S. Cuoco;Christopher Rodman.
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Alexander M. Menzies;Alexander M. Menzies;D. B. Johnson;S. Ramanujam;V. G. Atkinson.
Annals of Oncology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: